JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 1.920
0.00 (0.00%)
Jul 31, 2026, 3:30 PM HKT
JBM (Healthcare) Market Cap
JBM (Healthcare) has a market cap or net worth of 1.57 billion as of July 31, 2026. Its market cap has decreased by -35.54% in one year.
Market Cap
1.57B
Enterprise Value
1.84B
Revenue
834.63M
Ranking
n/a
PE Ratio
7.80
Stock Price
1.92
ChartMarket Cap Chart
Since February 5, 2021, JBM (Healthcare)'s market cap has decreased from 1.93B to 1.57B, a decrease of -18.46%. That is a compound annual growth rate of -3.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.57B | -27.60% |
| Dec 31, 2025 | 2.17B | 40.57% |
| Dec 31, 2024 | 1.55B | 71.27% |
| Dec 29, 2023 | 903.02M | 6.82% |
| Dec 30, 2022 | 845.38M | -8.16% |
| Dec 31, 2021 | 920.50M | -52.31% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edding Genor Group Holdings | 3.30B |
| Golden Throat Holdings Group Company | 2.35B |
| Hua Medicine (Shanghai) | 2.32B |
| CPBIO Holding Company | 2.27B |
| Jacobson Pharma Corporation | 2.14B |
| VISEN Pharmaceuticals | 2.10B |
| Dawnrays Pharmaceutical (Holdings) | 1.57B |
| Essex Bio-Technology | 1.38B |